Annals of the New York Academy of Sciences最新文献

In many group-living animals, survival and reproductive success depend on the formation of long-term social bonds, yet it remains largely unclear why particular pairs of groupmates form social bonds and not others. Can social bond formation be reliably predicted from each individual's immediately observable traits and behaviors at first encounter? Or is social bond formation hard to predict due to the impacts of shifting social preferences on social network dynamics? To begin to address these questions, we asked how well long-term cooperative relationships among vampire bats were predicted by how they interacted during their first encounter as introduced strangers. In Study 1, we found that the first 6 h of observed interactions among unfamiliar bats co-housed in small cages did not clearly predict the formation of allogrooming or food-sharing relationships over the next 10 months. In Study 2, we found that biologger-tracked first contacts during the first 4–24 h together in a flight cage did not strongly predict allogrooming rates over the next 4 months. These results corroborate past evidence that social bonding in vampire bats is not reducible to the individual traits or behaviors observed at first encounter. Put simply, first impressions are overshadowed by future social interactions.

Food and condiment fortification programs are needed to address micronutrient deficiencies and their health, developmental, and mortality consequences; but these programs are never free. Knowing program costs and their allocation across stakeholders is essential to design and manage effective, efficient, and sustainable programs. We developed 10-year hypothetical bouillon fortification program cost models for Nigeria, Senegal, and Burkina Faso that included start-up and operational costs for government and industry, as well as premix costs generated by an embedded premix cost calculator to allow for alternative premix formulas in cost calculations. The main drivers of total costs were total bouillon consumption and the types and amounts of fortificants in the micronutrient premix. For a premix that meets 30% of Codex Nutrient Reference Values in 2.5 g of bouillon for vitamin A, folate, vitamin B12, zinc, and iron, the cost per metric ton of fortified bouillon was ∼$325 for all countries (∼$0.01 per 2.5 g serving). Annual start-up costs ranged from ∼$324k (Burkina Faso) to ∼$455k (Nigeria); nonpremix annual operating costs ranged from ∼$108k (Burkina Faso) to ∼$3.9m (Nigeria); and annual premix costs varied from ∼$2.4m (Burkina Faso) to ∼$76m (Nigeria). In policy discussions, program costs should be set alongside nutritional benefits.

The neuroendocrine control of puberty and reproduction is fascinatingly complex, with up- and down-regulation of key reproductive hormones during fetal, infantile, and later childhood periods that determine the correct function of the hypothalamic–pituitary–gonadal axis and the timing of puberty. Neuronal development is a vital element of these processes, and multiple conditions of disordered puberty and reproduction have their etiology in abnormal neuronal migration or function. Although there are numerous documented cases across multiple conditions wherein patients have both neurodevelopmental disorders and pubertal abnormalities, this has mostly been described ad hoc and the associations are not clearly documented. In this review, we aim to describe the overlap between these two groups of conditions and to increase awareness to ensure that puberty and reproductive function are carefully monitored in patients with neurodevelopmental conditions, and vice versa. Moreover, this commonality can be explored for clues about the disease mechanisms in these patient groups and provide new avenues for therapeutic interventions for affected individuals.

Laryngopharyngeal reflux (LPR) manifests as a variety of nonspecific upper aerodigestive tract symptoms. Rather than a single disorder, LPR may be conceived of as a spectrum of subtypes with varying clinical presentations. LPR signs and symptoms arise from the direct and/or indirect effects of refluxate, physical and molecular injury of the mucosa, and neurologic responses to esophageal events. Specific constituents of refluxate exert distinct mucosal responses and immediate or delayed effects resulting in transient or persistent symptoms and/or laryngeal hypersensitivity. While the complex etiology of LPR presents challenges to its diagnosis and management, tools that aid the identification of LPR subtypes can provide insight into treatment decision-making. Hypopharyngeal-esophageal multichannel intraluminal impedance-pH monitoring provides detailed analysis of reflux events, enabling the development of individualized treatment plans, yet cost and availability limit its widespread use. Alginates offer temporary symptom relief and antireflux surgery may provide benefit when symptoms are recalcitrant to other approaches. Pepsin inhibitors hold promise as a medical therapy when surgery is not an option. Laryngeal hypersensitivity should be considered as part of a comprehensive therapeutic approach. Promising medical and scientific research continues to yield new insights into the complex etiology of LPR and novel strategies for its diagnosis and management.

The World Health Organization (WHO) has published new hemoglobin cutoff points for defining anemia and its measurement. This change could impact the prevalence of anemia, particularly in countries with populations living in high-altitude areas. This study estimates the national prevalences of anemia in children aged 6–59 months using Centers for Disease Control and Prevention (CDC) 1989 and WHO 2024 criteria. Data from 406,106 children in 48 countries (45 Demographic and Health Surveys [DHS Program] and 3 Andean [Ecuador, Bolivia, and Peru]) were analyzed. The pooled prevalence of anemia was 61.4% according to the WHO 2024 criteria. Three countries showed changes in anemia prevalence, with shifts of 10 or more percentage points (Uganda, Rwanda, and Jordan). Across all the studied countries, the prevalence of anemia was higher at greater altitudes, rural areas, and children from households of low wealth quintiles, regardless of the criteria used. Moreover, changes in anemia prevalence were identified when stratified by altitude of residence, showing differences in the levels of public health significance across various political–administrative regions in Andean countries. Overall, these findings provide valuable insights into the epidemiology of anemia and highlight the need for continued surveillance and targeted interventions to effectively address this global health challenge.

The world's rich diversity of bats supports healthy ecosystems and important ecosystem services. Maintaining healthy biological systems requires prompt identification of threats to biodiversity and immediate action to protect species, which for wide-ranging bat species that span geopolitical boundaries warrants international coordination. Anthropogenic forces drive the threats to bats throughout North America and the world. We conducted an international expert elicitation to assess the status of 153 bat species in Canada, the United States, and Mexico. We used expert assessment to determine the conservation status, highest impact threats, and recent population trends for these species. We found that 53% of North American bat species have moderate to very high risk of extinction in the next 15 years. The highest impact threats varied with species and country, and four IUCN threat categories had the greatest overall impacts: Climate Change, Problematic Species (including disease), Agriculture, and Energy Production. Experts estimated that 90% of species assessed had decreasing population trends over the past 15 years, demonstrating the need for conservation action. Although the state of North American bats is concerning, we identify threats that can be addressed through internationally collaborative, proactive, and protective actions to support the recovery and resilience of North American bat species.

Like the Romantics, Charles Darwin was deeply though fruitfully torn between the mechanist dictate to banish agency from nature and the organicist impulse to naturalize agency, to make agency synonymous with life. His conflicting intellectual inheritances and allegiances put him in a state of profound and extraordinarily productive ambivalence.

Over the last two decades, advancements in sequencing technologies have significantly deepened our understanding of the human microbiome's complexity, leading to increased concerns about the detrimental effects of antibiotics on these intricate microbial ecosystems. Concurrently, the rise in antimicrobial resistance has intensified the focus on how beneficial microbes can be harnessed to treat diseases and improve health and offer potentially promising alternatives to traditional antibiotic treatments. Here, we provide a comprehensive overview of both established and emerging microbe-centric therapies, from probiotics to advanced microbial ecosystem therapeutics, examine the sophisticated ways in which microbes are used medicinally, and consider their impacts on microbiome homeostasis and health outcomes through a microbial ecology lens. In addition, we explore the concept of rewilding the human microbiome by reintroducing “missing microbes” from nonindustrialized societies and personalizing microbiome modulation to fit individual microbial profiles—highlighting several promising directions for future research. Ultimately, the advancements in sequencing technologies combined with innovative microbial therapies and personalized approaches herald a new era in medicine poised to address antibiotic resistance and improve health outcomes through targeted microbiome management.

In this article, we explore the connections between two distinct approaches: experiential learning (EL) and 4E cognition. EL emphasizes the role of concrete experiences as the building blocks of learning, whereas 4E cognition views cognition as arising from the interactions that an individual has with their physical and social environment. Despite their divergent theoretical frameworks, methodologies, and interests, we argue that both frameworks share a common vision of cognition and that their integration could mutually enhance their respective fields. This article outlines the historical origins and underlying assumptions of both frameworks, highlighting the potential links that can be established between them. Specifically, we explore the significance of embodiment, embeddedness, extended cognition, and enactive processes in learning and cognition. To bridge these frameworks, we propose employing the concept of “concrete experience” as an active engagement of individuals with their physical and social surroundings. By encompassing the essential aspects assigned to concrete experiences in EL, as well as the embodiment, situatedness, extended cognition, and enactive features of 4E cognition, this notion serves as a unifying element. Ultimately, the article suggests that combining the insights from EL and 4E cognition can offer a richer, more holistic understanding of representation.

Atrial fibrillation (AF) is a severe condition associated with high morbidity and mortality, including an increased risk of stroke and poor outcomes poststroke. Our understanding of the prognosis in AF remains poor. Machine learning (ML) has been applied to the diagnosis, management, and prognosis of AF in the context of stroke but remains suboptimal for clinical use. This article endeavors to provide a comprehensive overview of current ML applications to AF patients at risk of stroke, as well as poststroke patients without AF. Strategies to develop effective ML involve the validation of a variety of ML algorithms across internal and external datasets as well as exploring their predictive powers in hypothetical and realistic settings. Recent literature of this rapidly evolving field has displayed much promise. However, further testing and innovation of medical artificial intelligence are required before its imminent introduction to ensure complete patient trust within the community. Prioritizing this research is imperative for advancing the optimization of ongoing care for AF patients, as well as the management of stroke patients with AF.